icer glp 1 releases obesity medicines white paper GLP-1 Agonists Treatments | Invigor

Given the pilot nature of the trial, the (relatively) small degree of weight loss achieved, and the well-described association between weight loss and fracture risk, we believe that further exploration into this increasingly relevant question is warranted

They can also order blood tests to check for underlying issues like thyroid disorders, autoimmune markers, or nutritional deficiencies that could be causing or contributing to your hair loss

[2] When to seek urgent advice: Contact your GP or healthcare provider promptly if you: Suspect you may be pregnant whilst taking GLP-1 medication Experience sudden changes in menstrual patterns Develop severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of gallbladder problems Experience severe, persistent vomiting or diarrhoea leading to dehydration Your healthcare team can coordinate care between endocrinology, gynaecology, and fertility services as needed, ensuring that your weight management and reproductive health goals are addressed safely and effectively

Although this side effect from taking GLP-1 agonists is rare, studies show an increased risk of developing NAION in people taking GLP-1 medications, says Manjot K

demonstrated that semaglutide had similar effects in an ovariectomized rat model, increasing -catenin expression and reducing RANKL production, which resulted in a net increase in bone formation

Another limitation is that for thyroid cancer, reporting specifically the cases of MTC vs